Antagonists of the corticotropin releasing factor receptor.

Prog Med Chem

Department of Chemistry, Neurocrine Biosciences, 10555 Science Center Drive, San Diego, CA 92121, USA.

Published: June 2003

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0079-6468(02)41006-5DOI Listing

Publication Analysis

Top Keywords

antagonists corticotropin
4
corticotropin releasing
4
releasing factor
4
factor receptor
4
antagonists
1
releasing
1
factor
1
receptor
1

Similar Publications

Background And Purpose: Alterations in tryptophan-kynurenine (TRP-KYN) pathway are implicated in major depressive disorder (MDD). α7 nicotinic acetylcholine (α7nACh) receptor regulates the hypothalamic-pituitary-adrenal (HPA) axis. We have shown that deficiency of kynurenine 3-monooxygenase (KMO) induces depression-like behaviour via kynurenic acid (KYNA; α7nACh antagonist).

View Article and Find Full Text PDF

Increased CRF-R1 transmission in the nucleus accumbens shell facilitates maternal neglect in lactating rats and mediates anxiety-like behaviour in a sex-specific manner.

Neuropharmacology

March 2025

Department of Behavioural and Molecular Neurobiology, Regensburg Center of Neuroscience, University of Regensburg, Regensburg, Germany. Electronic address:

During the transition to motherhood, complex brain adaptations occur to ensure adequate maternal responses to offspring' needs accompanied by reduced anxiety. Among others, the corticotropin-releasing factor (CRF) and oxytocin (OXT) systems have emerged as crucial regulators of these essential postpartum adaptations. Here, we investigated their roles within the nucleus accumbens shell (NAcSh), a central region of the reward and maternal circuits, in maternal neglect of lactating rats.

View Article and Find Full Text PDF

Direct modulation of CRH nerve terminal function by noradrenaline and corticosterone.

J Neurosci

December 2024

Centre for Neuroendocrinology and Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.

Nerve terminals are the final point of regulation before neurosecretion. As such, neuromodulators acting on nerve terminals can exert significant influence on neural signalling. Hypothalamic corticotropin-releasing hormone (CRH) neurons send axonal projections to the median eminence where CRH is secreted to stimulate the hypothalamic-pituitary-adrenal (HPA) axis.

View Article and Find Full Text PDF

Region-specific neuroadaptations of CRF1 and CRF2 expression following heroin exposure in female rats.

Pharmacol Biochem Behav

December 2024

Department of Psychological and Brain Sciences, Colgate University, Hamilton, NY, USA. Electronic address:

Article Synopsis
  • - Stress increases the risk of addiction and the role of corticotropin releasing factor (CRF) is critical, but how CRF1 and CRF2 receptors impact heroin use is not fully understood.
  • - In a study involving female rats, blocking CRF1 and CRF2 receptors reduced heroin self-administration, highlighting their importance in drug-seeking behavior.
  • - Chronic heroin exposure caused specific changes in CRF receptor expression in different brain regions, suggesting that these neuroadaptations may contribute to ongoing drug use and withdrawal symptoms.
View Article and Find Full Text PDF

4-Methoxycinnamic acid ameliorates post-traumatic stress disorder-like behavior in mice by antagonizing the CRF type 1 receptor.

Life Sci

January 2025

Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul 02447, Republic of Korea; Department of Oriental Pharmaceutical Science, Kyung Hee University, Seoul 02447, Republic of Korea. Electronic address:

Article Synopsis
  • PTSD is a serious mental health condition triggered by traumatic events, with symptoms like anxiety, depression, and negative mood changes.
  • Traditional treatments have limited effectiveness and side effects, prompting research into 4-methoxycinnamic acid (4-MCA) as a new potential therapy for PTSD.
  • Studies on mice showed that 4-MCA significantly reduced anxiety and depression, improved cognitive function, and corrected fear-related issues, suggesting it may work by impacting specific brain signaling pathways related to fear memory.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!